These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case]. Rosenberger K Nervenarzt; 1973 Sep; 44(9):484-7. PubMed ID: 4750027 [No Abstract] [Full Text] [Related]
10. [Wilson's disease: an unusual case]. Llagostera Campillo F; Garrido Botella A; Abreu García L; Barrios Peinado C; Gonzalo Molina MA; Pabón Jaén M; Chantar Barrios C; Fernández Corugedo A; Escartín Marín P Rev Esp Enferm Apar Dig; 1983 Jul; 64(1):43-8. PubMed ID: 6612070 [No Abstract] [Full Text] [Related]
11. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease). SCHEINBERG IH; GITLIN D Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898 [No Abstract] [Full Text] [Related]
12. Wilson's disease patients with normal ceruloplasmin levels. Yüce A; Koçak N; Ozen H; Gürakan F Turk J Pediatr; 1999; 41(1):99-102. PubMed ID: 10770682 [TBL] [Abstract][Full Text] [Related]
13. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease]. Kanai M; Nomoto S; Tsukagoshi H; Shindo M Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793 [No Abstract] [Full Text] [Related]
14. Treatment of hepatolenticular degeneration. (Wilson's disease). Spellberg MA Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739 [No Abstract] [Full Text] [Related]
15. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE. WALSHE JM Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274 [No Abstract] [Full Text] [Related]
16. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives. Prasad R; Kaur G; Walia BN Biol Trace Elem Res; 1998 Nov; 65(2):153-65. PubMed ID: 9881519 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the need of ceruloplasmin and serum copper analyses in the diagnosis of Wilson's disease]. Nomoto S; Kanai M; Matsuda Y Rinsho Byori; 1974 Oct; 22(10 Suppl):190. PubMed ID: 4475792 [No Abstract] [Full Text] [Related]
18. Studies on copper metabolism. XXIX. A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease. CARTWRIGHT GE; MARKOWITZ H; SHIELDS GS; WINTROBE MM Am J Med; 1960 Apr; 28():555-63. PubMed ID: 13808058 [No Abstract] [Full Text] [Related]
19. [New views on the etiology, diagnosis and therapy of Wilson's disease]. Linke A Z Arztl Fortbild (Jena); 1967 Dec; 61(24):1273-6. PubMed ID: 4873428 [No Abstract] [Full Text] [Related]
20. [CERULOPLASMIN CONTENT IN PATIENTS WITH HEPATOCEREBRAL DYSTROPHY AND IN THEIR HEALTHY RELATIVES]. MITTELSHTEDT AA; BAUMAN LK Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():819-21. PubMed ID: 14235907 [No Abstract] [Full Text] [Related] [Next] [New Search]